Pharmaceuticals, Biotechnology and Life Sciences
Dermira set to receive an option exercise fee of $50 million and additional potential milestone payments and royalties
Longboat Clinical, the clinical technology company specializing in site and patient engagement platforms, today announced the release of Patient CONNECT, a unique solution to streamline patient recruitment into clinical trials and provide much sought-after insights to drug development teams.
DUBLIN–(BUSINESS WIRE)–The “Patient Engagement in R&D: Still a Challenge” report has been added to ResearchAndMarkets.com’s offering. The pharmaceutical industry has…
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The biopharmaceuticals market is driven…
CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that multiple abstracts featuring the INTERCEPT Blood System pathogen reduction technology, including four…
-GENFIT partnership expands Terns’ portfolio, adding a Phase 3 product with a complementary mechanism of action well-suited to combinations with…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Eric…
U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates European Patent…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…